Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to obtain evidence of the safety of NNZ-2566 in healthy female volunteers and to determine the pharmacokinetics (PK) of NNZ-2566 in healthy female volunteers.


Clinical Trial Description

To obtain evidence of the safety of NNZ-2566 in healthy female volunteers, compared to placebo when administered as a 10 minute intravenous (i.v.) bolus infusion, and when administered as a 10-minute bolus infusion immediately followed by a continuous 72-hour maintenance infusion.

To determine the blood pharmacokinetics (PK) of an intravenous dose of NNZ-2566 in healthy female volunteers when administered as a 10-minute bolus infusion, and when administered as a 10-minute bolus followed by a continuous 72-hour maintenance infusion. ;


Study Design

Allocation: Randomized, Endpoint Classification: Safety Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT00961779
Study type Interventional
Source Neuren Pharmaceuticals Limited
Contact
Status Completed
Phase Phase 1
Start date March 2010
Completion date September 2010

See also
  Status Clinical Trial Phase
Recruiting NCT03504709 - REsting and Stimulus-based Paradigms to Detect Organized NetworkS and Predict Emergence of Consciousness
Not yet recruiting NCT03648476 - Intervention to Change Attributions That Are Negative (ICAN) N/A
Completed NCT02426749 - Treatment and Recovery Monitoring of Post TBI Symptoms N/A
Completed NCT01339702 - The EPIC Project: Impact of Implementing the EMS Traumatic Brain Injury Treatment Guidelines
Recruiting NCT03727737 - Efficacy of Repetitive Transcranial Magnetic Stimulation for Improvement of Memory in Older Adults With TBI N/A
Recruiting NCT03153397 - Effect of Prebiotic Fiber- Enriched (scFOS) Enteral Feeding on the Microbiome in Neurological Injury Trauma Patients (PreFEED Microbiome Trial) N/A
Not yet recruiting NCT02776488 - Metabolic Therapy for Traumatic Brain Injury Phase 1/Phase 2
Recruiting NCT02004080 - CREACTIVE - Collaborative REsearch on ACute Traumatic Brain Injury in intensiVe Care Medicine in Europe
Completed NCT01336413 - Neuroactive Steroids and Traumatic Brain Injury (TBI) in OEF/OIF Veterans Phase 2
Recruiting NCT03671083 - Validation of Brain Function Assessment Algorithm for mTBI From Initial Injury to Rehabilitation
Enrolling by invitation NCT02525432 - Autologous Stem Cell Study for Adult TBI (Phase 2b) Phase 2
Not yet recruiting NCT03429322 - Medical and Resource Facilitation Intervention After Traumatic Brain Injury N/A
Enrolling by invitation NCT02652598 - Evaluate the Effects of Tolcapone on Cognitive and Behavioral Dysfunction in Patients With BI and NCD Phase 2
Recruiting NCT03089749 - Characterization of Human Autoantibody Titers After Central Nervous System Insult
Active, not recruiting NCT02158494 - Noninvasive Neuromodulation for Treatment of Symptoms Due to Mild or Moderate Traumatic Brain Injury N/A
Active, not recruiting NCT01417468 - How Well do Patients With Traumatic Brain Injury Learn New Material Using Learning Styles in Online Science Classrooms? N/A
Terminated NCT00316004 - Hypertonic Resuscitation Following Severe Traumatic Brain Injury (TBI) Phase 3
Recruiting NCT02920788 - Mild TBI Assessment & Rehabilitation N/A
Recruiting NCT03068143 - Postoperative Temperature Monitoring In Brain Trauma N/A
Recruiting NCT03515967 - Testing Mild Traumatic Brain Injury (mTBI) in Diverse Athletic Groups N/A